Awesome interview, best type of PR you could ask for.
The Gene Tech promise will not the panacea anytime soon...even then you still need to reduce the inflammation = combination drug!
Sarepta licensed out their Gene Tech IP to Roche for $1B....food for thought re value of ANP's IP.
"Confidence inspiring" indeed Prof!
Blockbuster.
Prof Thomas Voit, DMD expert, interview with Wilsons advisory, page-8
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
0.8¢ |
Change
-0.001(5.88%) |
Mkt cap ! $8.699M | |||
| Open | High | Low | Value | Volume |
| 0.9¢ | 0.9¢ | 0.8¢ | $16.64K | 2.010M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 24 | 6525662 | 0.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.9¢ | 1987416 | 4 |
View Market Depth
| Last trade - 15.25pm 18/07/2025 (20 minute delay) ? |
| PER (ASX) Chart |